Amgen Inc. Stock News

Another exploration Titled "Worldwide Orphan Drugs 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern , item type and creation investigation considering central point,

Altfest L J & Co. Inc. boosted its stake in Amgen Inc. (NASDAQ:AMGN) by 57.7% during the third quarter, Holdings Channel.com reports. The institutional investor owned 6,485 shares of the medical research companys stock after acquiring an additional 2,373 shares during the period. Altfest L J & Co. Inc.s holdings in Amgen were worth $1,379,000 []

Wesbanco Bank Inc. lessened its stake in shares of Amgen Inc. (NASDAQ:AMGN) by 0.1% in the 3rd quarter, Holdings Channel reports. The firm owned 102,791 shares of the medical research companys stock after selling 109 shares during the period. Amgen accounts for 0.8% of Wesbanco Bank Inc.s investment portfolio, making the stock its 25th largest []

Equities researchers at BMO Capital Markets initiated coverage on shares of Amgen (NASDAQ:AMGN) in a research note issued on Thursday, PriceTargets.com reports. The brokerage set a market perform rating and a $228.00 price target on the medical research companys stock. BMO Capital Markets target price suggests a potential upside of 10.64% from the companys previous []

Rothschild Investment Corp IL cut its stake in shares of Amgen Inc. (NASDAQ:AMGN) by 15.3% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 71,090 shares of the medical research companys stock after selling 12,824 shares during the period. Amgen makes up approximately 1.3% of Rothschild Investment []

Within the last quarter, Amgen (NASDAQ: AMGN ) has observed the following analyst ratings:

Louisiana State Employees Retirement System lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN) by 1.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 64,700 shares of the medical research companys stock after selling 800 shares during the period. Louisiana State Employees Retirement []

To provide every minute information about the business scenario and industry developments, industry-based research and detailed market studies are conducted. The reach of this market analysis goes beyond the Prefilled Syringes Drug market basic outline by presenting details in the

The global Novel Drug Delivery Systems market was valued at 262.62 Million USD in 2020 and will grow with a CAGR of 2.01% from 2021 to 2027. The NDDS market is growing due to increased use of various controlled-release medications,

Related Stocks: AMGN , VIAC , GTES , LOPE , LMT , GBL , DISCK ,

Beese Fulmer Investment Management Inc. boosted its stake in Amgen Inc. (NASDAQ:AMGN) by 63.2% in the third quarter, Holdings Channel reports. The fund owned 3,163 shares of the medical research companys stock after buying an additional 1,225 shares during the quarter. Beese Fulmer Investment Management Inc.s holdings in Amgen were worth $673,000 as of its []

Moody National Bank Trust Division decreased its position in shares of Amgen Inc. (NASDAQ:AMGN) by 27.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,062 shares of the medical research companys stock after selling 393 shares during the quarter. Moody National Bank []

List of Companies profiled in the Report: AbbVie Inc. (Illinois, United States), Novartis AG (Basel, Switzerland), Johnson & Johnson Services, Inc. (New Jersey, United States), Pfizer Inc., (New York, United States), LEO Pharma A/S (Ballerup, Denmark), Merck & Co., Inc. (New Jersey, United States), Amgen Inc. (California, United States), Eli Lilly and Company (Indiana, United States), CELGENE CORPORATION (New Jersey, United States), UCB S.A. (Brussels, Belgium), Sun Pharmaceutical Industries Ltd. (Mumbai, India), Other prominent players List of Companies profiled in the Report: AbbVie Inc. (Illinois, United States), Novartis AG (Basel, Switzerland), Johnson & Johnson Services, Inc. (New Jersey, United States), Pfizer Inc., (New York, United States), LEO Pharma A/S (Ballerup, Denmark), Merck & Co., Inc. (New Jersey, United States), Amgen Inc. (California, United States), Eli Lilly and Company (Indiana, United States), CELGENE CORPORATION (New Jersey, United States), UCB S.A. (Brussels, Belgium), Sun Pharmaceutical Industries Ltd.

Overview of Global Bio Similar Market: The Global Bio Similar Market report is a skilful and deep analysis of the present situation and challenges. This report focuses on the key drivers, restraints, Market opportunities, threats and risks for Market major players.

Overview of Europe CAR-T Cell Therapy Treatment Market: The primary sources employed while crafting CAR-T Cell Therapy Treatment Market report include the industry experts from the Healthcare industry comprising the management corporation, processing organizations, analytical service suppliers of the industrys value